Claustres M, Guittard C, Bozon D, Chevalier F, Verlingue C, Ferec C, Girodon E, Cazeneuve C, Bienvenu T, Lalau G, Dumur V, Feldmann D, Bieth E, Blayau M, Clavel C, Creveaux I, Malinge M C, Monnier N, Malzac P, Mittre H, Chomel J C, Bonnefont J P, Iron A, Chery M, Georges M D
Laboratoire de Génétique Moléculaire, CHU, CNRS UPR 1142, Institut de Biologie, Montpellier, France.
Hum Mutat. 2000;16(2):143-56. doi: 10.1002/1098-1004(200008)16:2<143::AID-HUMU7>3.0.CO;2-J.
We have collated the results of cystic fibrosis (CF) mutation analysis conducted in 19 laboratories in France. We have analyzed 7, 420 CF alleles, demonstrating a total of 310 different mutations including 24 not reported previously, accounting for 93.56% of CF genes. The most common were F508del (67.18%; range 61-80), G542X (2.86%; range 1-6.7%), N1303K (2.10%; range 0.75-4.6%), and 1717-1G>A (1.31%; range 0-2.8%). Only 11 mutations had relative frequencies >0. 4%, 140 mutations were found on a small number of CF alleles (from 29 to two), and 154 were unique. These data show a clear geographical and/or ethnic variation in the distribution of the most common CF mutations. This spectrum of CF mutations, the largest ever reported in one country, has generated 481 different genotypes. We also investigated a cohort of 800 French men with congenital bilateral absence of the vas deferens (CBAVD) and identified a total of 137 different CFTR mutations. Screening for the most common CF defects in addition to assessment for IVS8-5T allowed us to detect two mutations in 47.63% and one in 24.63% of CBAVD patients. In a subset of 327 CBAVD men who were more extensively investigated through the scanning of coding/flanking sequences, 516 of 654 (78. 90%) alleles were identified, with 15.90% and 70.95% of patients carrying one or two mutations, respectively, and only 13.15% without any detectable CFTR abnormality. The distribution of genotypes, classified according to the expected effect of their mutations on CFTR protein, clearly differed between both populations. CF patients had two severe mutations (87.77%) or one severe and one mild/variable mutation (11.33%), whereas CBAVD men had either a severe and a mild/variable (87.89%) or two mild/variable (11.57%) mutations.
我们整理了法国19个实验室进行的囊性纤维化(CF)突变分析结果。我们分析了7420个CF等位基因,共发现310种不同突变,其中24种此前未报道,占CF基因的93.56%。最常见的突变是F508del(67.18%;范围61 - 80)、G542X(2.86%;范围1 - 6.7%)、N1303K(2.10%;范围0.75 - 4.6%)和1717 - 1G>A(1.31%;范围0 - 2.8%)。只有11种突变的相对频率>0.4%,140种突变仅在少数CF等位基因上发现(从29个到2个),154种为独特突变。这些数据表明最常见CF突变的分布存在明显的地理和/或种族差异。这一CF突变谱是一个国家报道过的最大规模的,共产生了481种不同基因型。我们还研究了800名患有先天性双侧输精管缺如(CBAVD)的法国男性队列,共鉴定出137种不同的CFTR突变。除了评估IVS8 - 5T外,筛查最常见的CF缺陷使我们在47.63%的CBAVD患者中检测到两种突变,在24.63%的患者中检测到一种突变。在通过扫描编码/侧翼序列进行更广泛研究的327名CBAVD男性子集中,654个等位基因中的516个(78.90%)被鉴定出来,分别有15.90%和70.95%的患者携带一种或两种突变,只有13.15%的患者未检测到任何CFTR异常。根据突变对CFTR蛋白的预期影响分类的基因型分布在这两个人群中明显不同。CF患者有两个严重突变(87.77%)或一个严重突变和一个轻度/可变突变(11.33%),而CBAVD男性有一个严重突变和一个轻度/可变突变(87.89%)或两个轻度/可变突变(11.57%)。